epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove amantadine
    generic
  • remove Furadantin
    nitrofurantoin
  • remove Krazati
    adagrasib
  • remove Monoferric
    ferric derisomaltose
  • remove Nesacaine
    chloroprocaine
  • remove Pexeva
    paroxetine
  • remove scopolamine
    generic

multicheck MultiCheck Results - 5 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face amantadine (generic) + scopolamine (generic)

Avoid/Use Alternative


amantadine + scopolamine

use alternative: combo may increase risk of CNS depression, psychomotor impairment, anticholinergic adverse effects (additive effects)

Smiley face Smiley face Pexeva (paroxetine) + scopolamine (generic)

Avoid/Use Alternative


paroxetine + scopolamine

use alternative: combo may increase risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

Smiley face Smiley face amantadine (generic) + Nesacaine (chloroprocaine)

Monitor/Modify Tx


amantadine + chloroprocaine

monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

Caution Advised

Smiley face Smiley face amantadine (generic) + Pexeva (paroxetine)

Caution Advised


amantadine + paroxetine

caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Smiley face Smiley face Furadantin (nitrofurantoin) + Nesacaine (chloroprocaine)

Caution Advised


nitrofurantoin + chloroprocaine

caution advised: combo may incr. risk of methemoglobinemia (additive effects)

Additional Considerations

Smiley face Smiley face paroxetine in Pexeva

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information